Know Cancer

or
forgot password

Positron Emission Tomography/Computed Tomography (PET/CT) for the Diagnosis of Recurrent Cancer: a Feasibility Study. PET in Recurrent Cancer(PETREC)


N/A
18 Years
N/A
Not Enrolling
Both
Non-small Cell Lung Cancer, Breast Cancer, Head and Neck Cancer, Ovarian Cancer, Esophageal Cancer, Lymphoma

Thank you

Trial Information

Positron Emission Tomography/Computed Tomography (PET/CT) for the Diagnosis of Recurrent Cancer: a Feasibility Study. PET in Recurrent Cancer(PETREC)


Inclusion Criteria:



- Patients with a previous history of non-small cell lung cancer, breast cancer, head
and neck cancer (not thyroid cancer), ovarian cancer, esophageal cancer, or lymphoma
(Hodgkin's or non-Hodgkin's) who have suspected recurrence on history and/or physical
exam.

- Conventional imaging (e.g., X-ray, ultrasound, CT, MRI, bone scan) is non-diagnostic.

Exclusion Criteria:

- Age less than 18 years.

- Patient with established recurrence requiring staging of recurrent disease.

- Patients who, at the time of the initial evaluation, have already undergone PET/CT
within 6 months prior to registration.

- Unable to lie supine for imaging with PET/CT.

- Pregnant or lactating female.

- Significant concurrent medical problems (e.g., uncontrolled diabetes, active cardiac
disease, significant chronic obstructive pulmonary disease) making the patient unfit
for further cancer therapy.

- Unable to give informed consent.

Type of Study:

Interventional

Study Design:

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

The number of patients recruited in 18 months and the clinical characteristics of patients who are enrolled in the study

Outcome Time Frame:

21 months

Safety Issue:

No

Principal Investigator

John J You, MD MSc FRCPC

Investigator Role:

Principal Investigator

Investigator Affiliation:

McMaster University

Authority:

Canada: Health Canada

Study ID:

OCOG-2007-PETREC

NCT ID:

NCT00686465

Start Date:

March 2009

Completion Date:

July 2012

Related Keywords:

  • Non-Small Cell Lung Cancer
  • Breast Cancer
  • Head and Neck Cancer
  • Ovarian Cancer
  • Esophageal Cancer
  • Lymphoma
  • recurrent cancer
  • PET/CT
  • FDG
  • planned management
  • actual treatment
  • Breast Neoplasms
  • Carcinoma, Non-Small-Cell Lung
  • Esophageal Diseases
  • Esophageal Neoplasms
  • Head and Neck Neoplasms
  • Lung Neoplasms
  • Lymphoma
  • Ovarian Neoplasms
  • Recurrence

Name

Location